Table 1 Base line
Volunteers characteristics | |
|---|---|
Variable | Total (n = 46) |
Age (years) | |
Mean | 46.4 (±9.7) |
Median (Q1–Q3) | 47.0 [42.0–51.5] |
Sexe n (%) woman | 13 (27 %) |
HIV infection diagnosis (years) | |
Mean | 12.4 (±7.9) |
Median (Q1–Q3) | 12.0 [4.8–20.3] |
Years since HIV RNA <40 copies/mL | |
Mean | 6.0 (±4.3) |
Median (Q1–Q3) | 4.6 [2.1–9.7] |
ART | |
Nucleoside base | 1 (2.1 %) |
Non nucleosidic | 28 (58.3 %) |
Protease | 15 (31.3 %) |
Integrase | 4 (8.3 %) |
HIV DNA (copies/106 PBMC) | |
Mean | 86.7 (±117.2) |
Median (Q1–Q3) | 49.5 [1.0–111.0] |
Log HIV DNA | |
Mean | 1.7 (±0.5) |
Median (Q1–Q3) | 1.7 [0.0–2.1] |
CD4 (cells per µL) | |
Mean | 692.4 (±259.6) |
Median | 666.0 [515.0–791.5] |
CD8 (cells per µL) | |
Mean | 688.3 (±309.8) |
Median (Q1–Q3) | 654.0 [475.0–753.0] |
CD4/CD8 | |
Mean | 1.1 (±0.4) |
Median (Q1–Q3) | 1.1 [0.8–1.4] |
Nadir (CD4 <350 cells per µL) (years) | |
Mean | 5.8 (±4.9) |
Median (Q1–Q3) | 4.4 [2.0–8.3] |
Nadir CD4 (cells per µL) | |
Mean | 336.3 (±114.0) |
Median (Q1–Q3) | 312.0 [265.0–390.0] |